Caitong International Asset Management Co. Ltd Trims Stake in Addus HomeCare Corporation $ADUS

Caitong International Asset Management Co. Ltd reduced its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 77.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 279 shares of the company’s stock after selling 976 shares during the period. Caitong International Asset Management Co. Ltd’s holdings in Addus HomeCare were worth $32,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Addus HomeCare during the 1st quarter worth $41,000. CWM LLC lifted its holdings in shares of Addus HomeCare by 25.3% during the 2nd quarter. CWM LLC now owns 554 shares of the company’s stock worth $64,000 after acquiring an additional 112 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Addus HomeCare by 26.4% during the 2nd quarter. GAMMA Investing LLC now owns 1,673 shares of the company’s stock worth $193,000 after acquiring an additional 349 shares during the last quarter. Stephens Inc. AR bought a new stake in shares of Addus HomeCare during the 2nd quarter worth $207,000. Finally, Bailard Inc. bought a new stake in shares of Addus HomeCare during the 1st quarter worth $208,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on ADUS. Royal Bank Of Canada lifted their price objective on shares of Addus HomeCare from $133.00 to $134.00 and gave the stock an “outperform” rating in a report on Friday, August 22nd. Wall Street Zen raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Sunday, June 29th. UBS Group started coverage on shares of Addus HomeCare in a report on Tuesday, September 2nd. They set a “buy” rating and a $145.00 price objective for the company. TD Cowen boosted their price target on shares of Addus HomeCare from $135.00 to $139.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Finally, Stephens reissued an “overweight” rating and issued a $140.00 price target on shares of Addus HomeCare in a research note on Wednesday, September 3rd. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $137.50.

Insider Transactions at Addus HomeCare

In other news, Director Veronica Hill-Milbourne sold 1,571 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total value of $180,555.03. Following the sale, the director directly owned 5,067 shares in the company, valued at approximately $582,350.31. This trade represents a 23.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brian Poff sold 7,739 shares of Addus HomeCare stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $116.82, for a total value of $904,069.98. Following the completion of the sale, the executive vice president owned 56,980 shares in the company, valued at approximately $6,656,403.60. This represents a 11.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 34,310 shares of company stock worth $3,958,375. 4.50% of the stock is currently owned by insiders.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS opened at $121.63 on Monday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17. The company has a 50-day moving average price of $114.83 and a 200-day moving average price of $111.47. The company has a market cap of $2.24 billion, a price-to-earnings ratio of 26.85, a price-to-earnings-growth ratio of 1.86 and a beta of 0.86. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.45 by $0.04. The company had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.Addus HomeCare’s revenue was up 21.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.35 EPS. As a group, equities analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.